Maternal polycystic ovary syndrome and the risk of autism spectrum disorders in the offspring: A population-based nationwide study in Sweden

Molecular Psychiatry

Volumn 21, Issue 10, 2016, Pages 1441-1448

  Kosidou, K ^a,b   Dalman, C ^a,b   Widman, L ^a,b   Arver, S ^b   Lee, B K ^c   Magnusson, C ^a,b   Gardner, R M ^b  

^a STOCKHOLM COUNTY COUNCIL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MALE; MATERNAL OBESITY; OVARY POLYCYSTIC DISEASE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; RISK; SWEDEN; CASE CONTROL STUDY; COMPLICATION; MOTHER; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR;

ADOLESCENT; ADULT; AUTISM SPECTRUM DISORDER; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; HUMANS; MALE; MOTHERS; ODDS RATIO; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SWEDEN;

EID: 84949256009     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.183     Document Type: Article

References (74)

1. Gillberg C, Cederlund M, Lamberg K, Zeijlon L. Brief report: "The autism epidemic". The registered prevalence of autism in a swedish urban area. J Autism Dev Disord 2006; 36: 429-435.
2. Rutter M, Caspi A, Moffitt TE. Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies. J Child Psychol Psychiatry 2003; 44: 1092-1115.
3. Idring S, Rai D, Dal H, Dalman C, Sturm H, Zander E et al. Autism spectrum disorders in the Stockholm Youth Cohort: design, prevalence and validity. PloS One 2012; 7: e41280.
4. Idring S, Lundberg M, Sturm H, Dalman C, Gumpert C, Rai D et al. Changes in prevalence of autism spectrum disorders in 2001-2011: findings from the Stockholm Youth Cohort. J Autism Dev Disord 2014; 45: 1766-1773.
5. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? Plos Biol 2011; 9: e1001081.
6. Happe F, Ronald A. The 'fractionable autism triad': a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol Rev 2008; 18: 287-304.
7. Auyeung B, Lombardo MV, Baron-Cohen S. Prenatal and postnatal hormone effects on the human brain and cognition. Pflugers Arch 2013; 465: 557-571.
8. Courchesne E, Campbell K, Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 2011; 1380: 138-145.
9. Nordahl CW, Scholz R, Yang XW, Buonocore MH, Simon T, Rogers S et al. Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders. A longitudinal study. Arch Gen Psychiatry 2012; 69: 53-61.
10. Herbert MR, Ziegler DA, Deutsch CK, O'Brien LM, Kennedy DN, Filipek PA et al. Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis. Brain 2005; 128: 213-226.
11. Baron-Cohen S. The extreme male brain theory of autism. Trends Cogn Sci 2002; 6: 248-254.
12. Jolliffe T, BaronCohen S. Are people with autism and Asperger syndrome faster than normal on the embedded figures test? J Child Psychol Psychiatry 1997; 38: 527-534.
13. Zettergren A, Jonsson L, Johansson D, Melke J, Lundstrom S, Anckarsater H et al. Associations between polymorphisms in sex steroid related genes and autistic-like traits. Psychoneuroendocrinology 2013; 38: 2575-2584.
14. Bejerot S, Eriksson JM, Bonde S, Canstrom K, Humble MB, Eriksson E. The extreme male brain revisited: gender coherence in adults with autism spectrum disorder. Br J Psychiatry 2012; 201: 116-123.
15. Ruta L, Ingudomnukul E, Taylor K, Chakrabarti B, Baron-Cohen S. Increased serum androstenedione in adults with autism spectrum conditions. Psychoneur-oendocrinology 2011; 36: 1154-1163.
16. Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the brain: Implications for explaining autism. Science 2005; 310: 819-823.
17. Baron-Cohen S, Auyeung B, Norgaard-Pedersen B, Hougaard D, Abdallah M, Melgaard L et al. Elevated fetal steroidogenic activity in autism. Mol Psychiatry 2015; 20: 369-376.
18. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434-2438.
19. Ehrmann DA. Medical progress: polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-1236.
20. Sanchon R, Gambineri A, Alpanes M, Angeles Martinez-Garcia M, Pasquali R, Escobar-Morreale HF. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Hum Reprod 2012; 27: 1209-1216.
21. Palomba S, Marotta R, Di Cello A, Russo T, Falbo A, Orio F et al. Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. Clin Endocrinol 2012; 77: 898-904.
22. Lyall K, Baker A, Hertz-Picciotto I, Walker CK. Infertility and its treatments in association with autism spectrum disorders: a review and results from the CHARGE study. Int J Environ Res Public Health 2013; 10: 3715-3734.
23. Lyall K, Pauls DL, Spiegelman D, Santangelo SL, Ascherio A. Fertility therapies, infertility and autism spectrum disorders in the Nurses' Health Study II. Paediatr Perinat Epidemiol 2012; 26: 361-372.
24. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-667.
25. Ludvigsson JF, Reichenberg A, Hultman CM, Murray JA. A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders. JAMA Psychiatry 2013; 70: 1224-1230.
26. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
27. Goverde AJ, Westerveld HE, Verhulst SM, Fauser BC. Polycystic ovary syndrome as a developmental disorder. Expert Rev Obstet Gynecol 2008; 3: 775-787.
28. Pinola P, Piltonen TT, Puurunen J, Vanky E, Sundstrom-Poromaa I, Stener-Victorin E et al. Androgen profile through life in women with polycystic ovary syndrome: a Nordic multicenter collaboration study. J Clin Endocrinol Metab 2015; 100: 3400-3407.
29. Idring S, Magnusson C, Lundberg M, Ek M, Rai D, Svensson AC et al. Parental age and the risk of autism spectrum disorders: findings from a Swedish population-based cohort. Int J Epidemiol 2014; 43: 107-115.
30. Rai D, Golding J, Magnusson C, Steer C, Lewis G, Dalman C. Prenatal and early life exposure to stressful life events and risk of autism spectrum disorders: population-based studies in Sweden and England. PloS One 2012; 7: e38893.
31. Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 2011; 343: d6309.
32. Abel KM, Dalman C, Svensson AC, Susser E, Dal H, Idring S et al. Deviance in fetal growth and risk of autism spectrum disorder. Am J Psychiatry 2013; 170: 391-398.
33. Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 2011; 128: 344-355.
34. Daan NMP, Louwers YV, Koster MPH, Eijkemans MJC, de Rijke YB, Lentjes EWG et al. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril 2014; 102: 1444-1451.
35. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocrine Rev 1999; 20: 535-582.
36. Albu A, Radian S, Fica S, Barbu C. Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients. Endocrine 2015; 48: 696-704.
37. Gardner RM, Lee BK, Magnusson C, Rai D, Frisell T, Karlsson H et al. Maternal body mass index during early pregnancy, gestational weight gain, and risk of autism spectrum disorders: Results from a Swedish total population and discordant sibling study. Int J Epidemiol 2015; 44: 870-883.
38. WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry Physical status: the use and interpretation of anthropometry. World Health Organization: Geneva, 1995, 452, Technical Report Series no. 854.
39. Ingudomnukul E, Baron-Cohen S, Wheelwright S, Knickmeyer R. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav 2007; 51: 597-604.
40. Pohl A, Cassidy S, Auyeung B, Baron-Cohen S. Uncovering steroidopathy in women with autism: a latent class analysis. Mol Autism 2014; 5: 27.
41. Maliqueo M, Sir-Petermann T, Perez V, Echiburu B, de Guevara AL, Galvez C et al. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94: 3282-3288.
42. McCarthy MM, Arnold AP. Reframing sexual differentiation of the brain. Nat Neurosci 2011; 14: 677-683.
43. Wegiel J, Flory M, Kuchna I, Nowicki K, Ma SY, Imaki H et al. Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum. Acta Neuropathol Commun 2014; 2: 141.
44. Bringas ME, Carvajal-Flores FN, Lopez-Ramirez TA, Atzori M, Flores G. Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder. Neuroscience 2013; 241: 170-187.
45. Kigar SL, Auger AP. Epigenetic mechanisms may underlie the aetiology of sex differences in mental health risk and resilience. J Neuroendocrinol 2013; 25: 1141-1150.
46. Olde Loohuis NF, Kole K, Glennon JC, Karel P, Van der Borg G, Van Gemert Y et al. Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism. Neurobiol Dis 2015; 80: 42-53.
47. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al. The Androgen Excess and PCOS Society criteria for the poly-cystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91: 456-488.
48. Huang A, Brennan K, Azziz R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010; 93: 1938-1941.
49. Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome-an analysis of 263 consecutive cases. Clin Endocrinol 1990; 32: 213-220.
50. Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 2013; 14: 95-109.
51. Livadas S, Pappas C, Karachalios A, Marinakis E, Tolia N, Drakou M et al. Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome. Endocrine 2014; 47: 631-638.
52. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002; 17: 2573-2579.
53. Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J Clin Endocrinol Metab 2010; 95: 2180-2186.
54. Barry JA, Kay AR, Navaratnarajah R, Iqbal S, Bamfo J, David AL et al. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J Obstet Gynaecol 2010; 30: 444-446.
55. Maliqueo M, Lara HE, Sanchez F, Echiburu B, Crisosto N, Sir-Petermann T. Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013; 166: 151-155.
56. Crisosto N, Echiburu B, Maliqueo M, Perez V, de Guevara AL, Preisler J et al. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters. Fertil Steril 2012; 97: 218-224.
57. Sir-Petermann T, Codner E, Perez V, Echiburu B, Maliqueo M, de Guevara AL et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94: 1923-1930.
58. Sir-Petermann T, Echiburu B, Maliqueo MM, Crisosto N, Sanchez F, Hitschfeld C et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod 2007; 22: 1830-1836.
59. Uzelac PS, Li X, Lin J, Neese LD, Lin L, Nakajima ST et al. Dysregulation of Leptin and Testosterone Production and Their Receptor Expression in the Human Placenta with Gestational Diabetes Mellitus. Placenta 2010; 31: 581-588.
60. Uzelac PS, Lee J, Zhang XH, Paulson RJ, Miller DA, Stanczyk FZ. Gestational diabetes augments hyperandrogenemia in the third trimester of pregnancy. J Soc Gynecol Invest 2005; 12: 282A-282A.
61. Barbieri RL, Saltzman DH, Torday JS, Randall RW, Frigoletto FD, Ryan KJ. Elevated concentrations of the beta-subunit of human chorionic-gonadotropin and testosterone in the amniotic-fluid of gestations of diabetic mothers. Am J Obstet Gynecol 1986; 154: 1039-1043.
62. de Medeiros SF, Barbosa JS, Yamamoto MMW. Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women. J Obstet Gynaecol Res 2015; 41: 254-263.
63. Doi SAR, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Steroidogenic alterations and adrenal androgen excess in PCOS. Steroids 2006; 71: 751-759.
64. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. Dysregulation of cytochrome-P450C17-alpha as the cause of polycystic ovarian syndrome. Fertil Steril 1990; 53: 785-791.
65. Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C et al. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and asperger syndrome. Autism Res 2009; 2: 157-177.
66. Pusalkar M, Meherji P, Gokral J, Chinnaraj S, Maitra A. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil Steril 2009; 92: 653-659.
67. Li Y, Liu F, Luo S, Hu H, Li XH, Li SW. Polymorphism T -4 C of gene CYP17 promoter and polycystic ovary syndrome risk: a meta-analysis. Gene 2012; 495: 16-22.
68. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992; 327: 157-162.
69. Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 1997; 82: 4075-4079.
70. Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S, Hansen RL et al. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 2012; 129: e1121-e1128.
71. Bohler H Jr., Mokshagundam S, Winters SJ. Adipose tissue and reproduction in women. Fertil Steril 2010; 94: 795-825.
72. McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperan-drogenism. J Clin Endocrinol Metab 2006; 91: 1714-1722.
73. Bay B, Mortensen EL, Hvidtjorn D, Kesmodel US. Fertility treatment and risk of childhood and adolescent mental disorders: register based cohort study. BMJ 2013; 347: f3978.
74. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89: 453-462.